Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
TRK-950 Combinations for Ovarian Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing the safety and ideal dosage of the drug TRK-950 when used in combination with various other cancer treatments.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.